Radical external beam radiotherapy for clinically localized prostate cancer in Japan: Differences in the patterns of care between Japan and the United States

Kazuhiko Ogawa, Katsumasa Nakamura, Hiroshi Onishi, Tomonari Sasaki, Masahiko Koizumi, Yoshiyuki Shioyama, Takafumi Komiyama, Yuuki Miyabe, Teruki Teshima

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The current study focused on the differences in the patterns of care between Japan and the United States for clinically localized prostate cancer patients treated with radical external beam radiotherapy. Materials and Methods: Results from the 1999-2001 Japanese Patterns of Care Study (PCS) survey were compared with those of the 1999 PCS in the United States. In addition, the changing trends in the patterns of care between Japan and the United States were also analyzed. Results: Patients in Japan were found to have more advanced pnmary disease than patients in the United States: with higher PSA levels, advanced T stages and a Gleason combined score of 8-10. These patient characteristics in both countries have not changed from previous PCS studies. The prescribed dose of radiotherapy to the primary tumor was significantly higher in the United States and there was a rapid increase in patients treated with higher prescription dose levels (≥72 Gy) in the United States, while only a small number of patients received these dose levels in Japan. Hormonal therapy was used more frequently in Japan than in the United States, and the percentage of patients receiving hormonal therapy has remained high for several years in Japan. Furthermore, most of the patients in the favorable risk group in Japan were treated with hormonal therapy, contrary to those in the United States. Conclusion: Japanese prostate cancer patients treated with radical external beam radiotherapy were found to have more advanced disease than those in the United States and these trends have continued for the last few years. Patterns of care for prostate cancer in Japan are considerably different from those in the United States, especially in terms of the radiation dose and the use of hormonal therapy. Moreover, the changing trends in the patterns of care are also different between the two countries.

Original languageEnglish
Pages (from-to)575-580
Number of pages6
JournalAnticancer research
Volume26
Issue number1 B
Publication statusPublished - Jan 1 2006

Fingerprint

Prostatic Neoplasms
Japan
Radiotherapy
Neoplasm Grading
Therapeutics
Prescriptions
Radiation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Radical external beam radiotherapy for clinically localized prostate cancer in Japan : Differences in the patterns of care between Japan and the United States. / Ogawa, Kazuhiko; Nakamura, Katsumasa; Onishi, Hiroshi; Sasaki, Tomonari; Koizumi, Masahiko; Shioyama, Yoshiyuki; Komiyama, Takafumi; Miyabe, Yuuki; Teshima, Teruki.

In: Anticancer research, Vol. 26, No. 1 B, 01.01.2006, p. 575-580.

Research output: Contribution to journalArticle

Ogawa, Kazuhiko ; Nakamura, Katsumasa ; Onishi, Hiroshi ; Sasaki, Tomonari ; Koizumi, Masahiko ; Shioyama, Yoshiyuki ; Komiyama, Takafumi ; Miyabe, Yuuki ; Teshima, Teruki. / Radical external beam radiotherapy for clinically localized prostate cancer in Japan : Differences in the patterns of care between Japan and the United States. In: Anticancer research. 2006 ; Vol. 26, No. 1 B. pp. 575-580.
@article{a987fb2021044d38bad21f7db0752efb,
title = "Radical external beam radiotherapy for clinically localized prostate cancer in Japan: Differences in the patterns of care between Japan and the United States",
abstract = "The current study focused on the differences in the patterns of care between Japan and the United States for clinically localized prostate cancer patients treated with radical external beam radiotherapy. Materials and Methods: Results from the 1999-2001 Japanese Patterns of Care Study (PCS) survey were compared with those of the 1999 PCS in the United States. In addition, the changing trends in the patterns of care between Japan and the United States were also analyzed. Results: Patients in Japan were found to have more advanced pnmary disease than patients in the United States: with higher PSA levels, advanced T stages and a Gleason combined score of 8-10. These patient characteristics in both countries have not changed from previous PCS studies. The prescribed dose of radiotherapy to the primary tumor was significantly higher in the United States and there was a rapid increase in patients treated with higher prescription dose levels (≥72 Gy) in the United States, while only a small number of patients received these dose levels in Japan. Hormonal therapy was used more frequently in Japan than in the United States, and the percentage of patients receiving hormonal therapy has remained high for several years in Japan. Furthermore, most of the patients in the favorable risk group in Japan were treated with hormonal therapy, contrary to those in the United States. Conclusion: Japanese prostate cancer patients treated with radical external beam radiotherapy were found to have more advanced disease than those in the United States and these trends have continued for the last few years. Patterns of care for prostate cancer in Japan are considerably different from those in the United States, especially in terms of the radiation dose and the use of hormonal therapy. Moreover, the changing trends in the patterns of care are also different between the two countries.",
author = "Kazuhiko Ogawa and Katsumasa Nakamura and Hiroshi Onishi and Tomonari Sasaki and Masahiko Koizumi and Yoshiyuki Shioyama and Takafumi Komiyama and Yuuki Miyabe and Teruki Teshima",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "26",
pages = "575--580",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 B",

}

TY - JOUR

T1 - Radical external beam radiotherapy for clinically localized prostate cancer in Japan

T2 - Differences in the patterns of care between Japan and the United States

AU - Ogawa, Kazuhiko

AU - Nakamura, Katsumasa

AU - Onishi, Hiroshi

AU - Sasaki, Tomonari

AU - Koizumi, Masahiko

AU - Shioyama, Yoshiyuki

AU - Komiyama, Takafumi

AU - Miyabe, Yuuki

AU - Teshima, Teruki

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The current study focused on the differences in the patterns of care between Japan and the United States for clinically localized prostate cancer patients treated with radical external beam radiotherapy. Materials and Methods: Results from the 1999-2001 Japanese Patterns of Care Study (PCS) survey were compared with those of the 1999 PCS in the United States. In addition, the changing trends in the patterns of care between Japan and the United States were also analyzed. Results: Patients in Japan were found to have more advanced pnmary disease than patients in the United States: with higher PSA levels, advanced T stages and a Gleason combined score of 8-10. These patient characteristics in both countries have not changed from previous PCS studies. The prescribed dose of radiotherapy to the primary tumor was significantly higher in the United States and there was a rapid increase in patients treated with higher prescription dose levels (≥72 Gy) in the United States, while only a small number of patients received these dose levels in Japan. Hormonal therapy was used more frequently in Japan than in the United States, and the percentage of patients receiving hormonal therapy has remained high for several years in Japan. Furthermore, most of the patients in the favorable risk group in Japan were treated with hormonal therapy, contrary to those in the United States. Conclusion: Japanese prostate cancer patients treated with radical external beam radiotherapy were found to have more advanced disease than those in the United States and these trends have continued for the last few years. Patterns of care for prostate cancer in Japan are considerably different from those in the United States, especially in terms of the radiation dose and the use of hormonal therapy. Moreover, the changing trends in the patterns of care are also different between the two countries.

AB - The current study focused on the differences in the patterns of care between Japan and the United States for clinically localized prostate cancer patients treated with radical external beam radiotherapy. Materials and Methods: Results from the 1999-2001 Japanese Patterns of Care Study (PCS) survey were compared with those of the 1999 PCS in the United States. In addition, the changing trends in the patterns of care between Japan and the United States were also analyzed. Results: Patients in Japan were found to have more advanced pnmary disease than patients in the United States: with higher PSA levels, advanced T stages and a Gleason combined score of 8-10. These patient characteristics in both countries have not changed from previous PCS studies. The prescribed dose of radiotherapy to the primary tumor was significantly higher in the United States and there was a rapid increase in patients treated with higher prescription dose levels (≥72 Gy) in the United States, while only a small number of patients received these dose levels in Japan. Hormonal therapy was used more frequently in Japan than in the United States, and the percentage of patients receiving hormonal therapy has remained high for several years in Japan. Furthermore, most of the patients in the favorable risk group in Japan were treated with hormonal therapy, contrary to those in the United States. Conclusion: Japanese prostate cancer patients treated with radical external beam radiotherapy were found to have more advanced disease than those in the United States and these trends have continued for the last few years. Patterns of care for prostate cancer in Japan are considerably different from those in the United States, especially in terms of the radiation dose and the use of hormonal therapy. Moreover, the changing trends in the patterns of care are also different between the two countries.

UR - http://www.scopus.com/inward/record.url?scp=32144456803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32144456803&partnerID=8YFLogxK

M3 - Article

C2 - 16739323

AN - SCOPUS:32144456803

VL - 26

SP - 575

EP - 580

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 B

ER -